Precipio, Inc. (PRPO)
NCM · Diagnostics & Research
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Peers in Diagnostics & Research
All in industry →Thermo Fisher Scientific Inc.
Danaher Corporation
IDEXX Laboratories, Inc.
Agilent Technologies, Inc.
Waters Corporation
Natera, Inc.
IQVIA Holdings Inc.
Mettler-Toledo International Inc.
Labcorp Holdings Inc.
Quest Diagnostics Incorporated
Recent press releases
Precipio, Inc. has not issued a press release in this window.
SEC filings
All filings →Precipio, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Precipio, Inc. has no reported insider trades in the last 90 days.